R.P. Riemsma

3.4k total citations · 1 hit paper
45 papers, 2.5k citations indexed

About

R.P. Riemsma is a scholar working on Rheumatology, Hepatology and Oncology. According to data from OpenAlex, R.P. Riemsma has authored 45 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 11 papers in Hepatology and 9 papers in Oncology. Recurrent topics in R.P. Riemsma's work include Rheumatoid Arthritis Research and Therapies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). R.P. Riemsma is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). R.P. Riemsma collaborates with scholars based in United Kingdom, Netherlands and Poland. R.P. Riemsma's co-authors include Erik Taal, Johannes J. Rasker, Mark Sculpher, Su Golder, John Kirwan, Julie Glanville, Laura Ginnelly, Karl Claxton, Z Philips and Jos Kleijnen and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Obesity Reviews and Archives of Disease in Childhood.

In The Last Decade

R.P. Riemsma

45 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

2004 528 citations Z Philips, Laura Ginnelly et al. Health Technology Assessment profile →

Peers

Countries citing papers authored by R.P. Riemsma

Since Specialization

Citations

This map shows the geographic impact of R.P. Riemsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.P. Riemsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.P. Riemsma more than expected).

Fields of papers citing papers by R.P. Riemsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.P. Riemsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.P. Riemsma. The network helps show where R.P. Riemsma may publish in the future.

Co-authorship network of co-authors of R.P. Riemsma

This figure shows the co-authorship network connecting the top 25 collaborators of R.P. Riemsma. A scholar is included among the top collaborators of R.P. Riemsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.P. Riemsma. R.P. Riemsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 ·Cochrane Database of Systematic Reviews ·Mateusz J Świerz, Dawid Storman, R.P. Riemsma, Robert Wolff, Jerzy Mituś, Michał Pędziwiatr, Jos Kleijnen, Małgorzata M Bała	10
2	Electro-coagulation for liver metastases 2013 ·Cochrane Database of Systematic Reviews ·R.P. Riemsma, Małgorzata M Bała, Robert Wolff, Jos Kleijnen	1
3	Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases 2012 ·Cochrane Database of Systematic Reviews ·R.P. Riemsma, Małgorzata M Bała, Robert Wolff, Jos Kleijnen	14
4	Hearing screening in newborns: systematic review of accuracy, effectiveness, and effects of interventions after screening 2009 ·Archives of Disease in Childhood ·Robert Wolff, (unknown), R.P. Riemsma, Gerd Antes, Stefan Lange, Jos Kleijnen	63
5	Loneliness among women with rheumatoid arthritis: a cross-cultural study in the Netherlands and Egypt 2008 ·Clinical Rheumatology ·(unknown), Erik Taal, Ahmed M. Abdel-Nasser, R.P. Riemsma, R. M. Mahfouz, (unknown), (unknown), Johannes J. Rasker	11
6	Systematic Review of the (Cost-)effectiveness of Spinal Cord Stimulation for People With Failed Back Surgery Syndrome 2008 ·Clinical Journal of Pain ·Małgorzata M Bała, R.P. Riemsma, John Nixon, Jos Kleijnen	74
7	A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents 2006 ·Health Technology Assessment ·Sarah King, Susan Griffin, Z. Hodges, Helen Weatherly, Christian Asseburg, Gerry Richardson, Su Golder, E. Taylor, Murray Drummond, R.P. Riemsma	133
8	Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation 2006 ·Health Technology Assessment ·Caroline Main, Laura Bojke, Susan Griffin, Gill Norman, Marco Barbieri, Lisa Mather, Dan Stark, Stephen Palmer, R.P. Riemsma	142
9	Need for high-quality studies in health technology assessments: The case of a systematic review of treatment for retinoblastoma 2006 ·International Journal of Technology Assessment in Health Care ·(unknown), Suzanne Hartley, Anne‐Marie Bagnall, (unknown), Kate Light, R.P. Riemsma	1
10	Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation 2004 ·Health Technology Assessment ·Lisa Jones, Susan Griffin, Stephen Palmer, Caroline Main, (unknown), Mark Sculpher, Cathie Sudlow, Raymond Henderson, (unknown), R.P. Riemsma	64
11	Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation 2004 ·Health Technology Assessment ·Caroline Main, Suetonia C. Palmer, Susan Griffin, Lisa Jones, (unknown), Mark Sculpher, R Henderson, Cathie Sudlow, Neil Hawkins, R.P. Riemsma	111
12	Review of guidelines for good practice in decision-analytic modelling in health technology assessment breakdown → 2004 ·Health Technology Assessment ·Z Philips, Laura Ginnelly, Mark Sculpher, Karl Claxton, Su Golder, R.P. Riemsma, (unknown), Julie Glanville	528
13	A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder 2004 ·Health Technology Assessment ·Christopher Bridle, Suetonia C. Palmer, (unknown), Josep Darbà, Steven Duffy, Mark Sculpher, R.P. Riemsma	104
14	Systematic review of rheumatoid arthritis patient education 2004 ·Arthritis Care & Research ·R.P. Riemsma, Erik Taal, John Kirwan, Johannes J. Rasker	96
15	A systematic review of the clinical effectiveness of orlistat used for the management of obesity 2004 ·Obesity Reviews ·Susan O’Meara, R.P. Riemsma, Liz Shirran, Lisa Mather, Gerben ter Riet	70
16	Group education for patients with rheumatoid arthritis and their partners 2003 ·Arthritis Care & Research ·R.P. Riemsma, Erik Taal, Johannes J. Rasker	94
17	Perceptions about perceived functional disabilities and pain of people with rheumatoid arthritis: Differences between patients and their spouses and correlates with well-being 2000 ·Arthritis & Rheumatism ·R.P. Riemsma, Erik Taal, Johannes J. Rasker	64
18	Coordinated individual education with an arthritis passport for patients with rheumatoid arthritis 1997 ·Arthritis & Rheumatism ·R.P. Riemsma, Erik Taal, Herman L. M. Brus, Johannes J. Rasker, O. Wiegman	41
19	EVALUATION OF A DUTCH VERSION OF THE AIMS2 FOR PATIENTS WITH RHEUMATOID ARTHRITIS 1996 ·Lara D. Veeken ·R.P. Riemsma, Erik Taal, Johannes J. Rasker, P. M. Houtman, H. C. Van Paassen, O. Wiegman	84
20	Changes in physical and psychosocial health status 1994 ·Scandinavian Journal of Rheumatology ·Johannes J. Rasker, Erik Taal, R.P. Riemsma	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact